Skip to content
MarketScale
‹ Back to IndustriesHealthcare

In MedTech, How Do You Define a User Need? with Nick Lesniewski-Laas of Sunrise Labs

The fundamental question that comes with designing new MedTech devices is this one: What are the user needs and requirements? The questions feels simple enough, but it’s far from simple. With that question comes others: Who is the user? What makes a good requirement? How do you actually test these requirements? For a MedTech…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

The fundamental question that comes with designing new MedTech devices is this one: What are the user needs and requirements? The questions feels simple enough, but it’s far from simple. With that question comes others: Who is the user? What makes a good requirement? How do you actually test these requirements? For a MedTech designer like Nick Lesniewski-Laas, Director of Electrical Engineering for Sunrise Labs, these questions can often inhibit his ability to deliver on quality products if the communication between all parties isn’t consistent and straight-forward. “I’m in the business of designing medical devices because I want to help people and I want to make sure that the devices I design are best able to do that,” Lesniewski-Laas said. “So, a lot of guidelines around requirements writing are aimed toward that but don’t really hit the mark in my opinion.”

On today’s Healthcare podcast, Lesniewski-Laas digs into this multi-layered question of delivering on user needs and defining needs versus requirements versus actual mandated FDA requirements. “By far the most important things to me are ‘unambiguous’ and ‘testable,’ or ‘verifiable,'” Lesniewski-Laas said. He breaks down the importance of atomicity, the way user needs affect everyone from the manufacturers to the patients, and his process for getting everyone involved on the same page so the potentially life-saving product can make its way efficiently to market.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @HealthMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Healthcare digital transformation stalls when teams stay disconnected

Healthcare digital transformation stalls when teams stay disconnected

Despite over 70% of healthcare executives prioritizing digital transformation, fragmented communication and information silos are hindering progress. Effective teamwork and integration are critical for achieving these goals. Bridging these gaps could enhance results in the healthcare industry's digital initiatives.

  • 01Over 70% of healthcare executives prioritize digital transformation.
  • 02Fragmented communication and information silos limit progress.
  • 03Effective integration is crucial for successful digital initiatives.

Jul 15, 2026

The Future of Healthcare Is Already Here: Dr. Geoffrey Rutledge on Virtual Care, AI, and Access

The Future of Healthcare Is Already Here: Dr. Geoffrey Rutledge on Virtual Care, AI, and Access

The article discusses the advancements in healthcare with a focus on virtual care, AI, and access, featuring insights from Dr. Geoffrey Rutledge. It explores how these technologies are shaping the future of healthcare delivery. The conversation touches upon the impact on patient care and the potential for improved healthcare accessibility.

  • 01Virtual care and AI are transforming healthcare.
  • 02These technologies enhance patient accessibility and care.
  • 03Healthcare delivery is continuously evolving with new innovations.

Jul 14, 2026

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512